Digestive health plays a crucial role in overall well-being, and gastrointestinal disorders are among the most common health issues affecting people globally. Conditions such as acid reflux, gastroesophageal reflux disease (GERD), and functional dyspepsia can severely impact a patient’s quality of life. Among the most effective pharmaceutical treatments for such disorders is the combination of Esomeprazole and Domperidone, available in Sustained Release (SR) capsule form.
Monark Biocare, a trusted name in the Indian pharmaceutical sector, offers Esomeprazole Domperidone (SR) Capsules as part of its high-quality, GMP-compliant product lineup. The company is also inviting dynamic entrepreneurs and healthcare professionals to explore PCD Pharma Franchise opportunities, allowing partners to grow with a rapidly expanding brand.
1. Esomeprazole (20mg or 40mg depending on formulation)
Esomeprazole is a proton pump inhibitor (PPI) that reduces gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.
Reduces gastric acidity effectively
Provides relief in GERD, peptic ulcer, and erosive esophagitis
Promotes healing of gastric mucosa
Offers long-term symptom relief
2. Domperidone (30mg SR)
Domperidone is a dopamine D2 receptor antagonist that acts peripherally to promote gastric motility and prevent nausea and vomiting.
Enhances gastric emptying
Improves symptoms of nausea and bloating
Reduces the risk of regurgitation
Especially useful in patients with delayed gastric emptying or functional dyspepsia
Combination Rationale:
The pairing of Esomeprazole and Domperidone works synergistically. Esomeprazole reduces the acid burden, while Domperidone ensures timely gastric emptying and motility. The SR (Sustained Release) formulation of Domperidone allows for extended symptom relief throughout the day, enhancing patient compliance and efficacy.
Esomeprazole Domperidone SR Capsules are primarily prescribed for: